Found: 34
Select item for more details and to access through your institution.
Genome-wide methylation sequencing identifies progression-related epigenetic drivers in myelodysplastic syndromes.
- Published in:
- Cell Death & Disease, 2020, v. 11, n. 11, p. 1, doi. 10.1038/s41419-020-03213-2
- By:
- Publication type:
- Article
Reduced protocadherin17 expression in leukemia stem cells: the clinical and biological effect in acute myeloid leukemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Down-regulation of miR-29c is a prognostic biomarker in acute myeloid leukemia and can reduce the sensitivity of leukemic cells to decitabine.
- Published in:
- Cancer Cell International, 2019, v. 19, n. 1, p. N.PAG, doi. 10.1186/s12935-019-0894-y
- By:
- Publication type:
- Article
SLIT2 promoter hypermethylation predicts disease progression in chronic myeloid leukemia.
- Published in:
- European Journal of Medical Research, 2022, v. 27, n. 1, p. 1, doi. 10.1186/s40001-022-00899-2
- By:
- Publication type:
- Article
Malocclusion Generates Anxiety-Like Behavior Through a Putative Lateral Habenula–Mesencephalic Trigeminal Nucleus Pathway.
- Published in:
- Frontiers in Molecular Neuroscience, 2019, p. 1, doi. 10.3389/fnmol.2019.00174
- By:
- Publication type:
- Article
BCL2 overexpression: clinical implication and biological insights in acute myeloid leukemia.
- Published in:
- Diagnostic Pathology, 2019, v. 14, n. 1, p. 1, doi. 10.1186/s13000-019-0841-1
- By:
- Publication type:
- Article
Identification and validation of prognosis‐related DLX5 methylation as an epigenetic driver in myeloid neoplasms.
- Published in:
- Clinical & Translational Medicine, 2020, v. 10, n. 2, p. 1, doi. 10.1002/ctm2.29
- By:
- Publication type:
- Article
<italic>H19</italic> overexpression promotes leukemogenesis and predicts unfavorable prognosis in acute myeloid leukemia.
- Published in:
- Clinical Epigenetics, 2018, v. 10, n. 1, p. N.PAG, doi. 10.1186/s13148-018-0486-z
- By:
- Publication type:
- Article
Decreased <italic>SCIN</italic> expression, associated with promoter methylation, is a valuable predictor for prognosis in acute myeloid leukemia.
- Published in:
- Molecular Carcinogenesis, 2018, v. 57, n. 6, p. 735, doi. 10.1002/mc.22794
- By:
- Publication type:
- Article
Reduced intensity conditioning of allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia in patients older than 50 years of age: a systematic review and meta-analysis.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 9, p. 1853, doi. 10.1007/s00432-017-2429-z
- By:
- Publication type:
- Article
DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 14, p. 6393, doi. 10.1002/cam4.2540
- By:
- Publication type:
- Article
Clinical Significance of Low Expression of LncRNA CASC15 in Acute Myeloid Leukemia with NPM1 Mutations.
- Published in:
- Journal of Experimental Hematology / Zhongguo Shiyan Xueyexue Zazhi, 2022, v. 30, n. 3, p. 659, doi. 10.19746/j.cnki.issn1009-2137.2022.03.002
- By:
- Publication type:
- Article
Overexpression of LncRNA ITGB2-AS1 Predicts Adverse Prognosis in Acute Myeloid Leukemia.
- Published in:
- Journal of Experimental Hematology / Zhongguo Shiyan Xueyexue Zazhi, 2021, v. 29, n. 5, p. 1436, doi. 10.19746/j.cnki.issn1009-2137.2021.05.011
- By:
- Publication type:
- Article
DNA methylation-mediated differential expression of DLX4 isoforms has opposing roles in leukemogenesis.
- Published in:
- 2022
- By:
- Publication type:
- Letter
DNA methylation-mediated differential expression of DLX4 isoforms has opposing roles in leukemogenesis.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Identification and validation of obesity-related gene LEP methylation as a prognostic indicator in patients with acute myeloid leukemia.
- Published in:
- Clinical Epigenetics, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13148-021-01013-9
- By:
- Publication type:
- Article
Pan‐cancer analysis identifies CD300 molecules as potential immune regulators and promising therapeutic targets in acute myeloid leukemia.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 1, p. 789, doi. 10.1002/cam4.4905
- By:
- Publication type:
- Article
Integrated analysis reveals distinct molecular, clinical, and immunological features of B7‐H3 in acute myeloid leukemia.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 21, p. 7831, doi. 10.1002/cam4.4284
- By:
- Publication type:
- Article
Abnormal expression and methylation of PRR34‐AS1 are associated with adverse outcomes in acute myeloid leukemia.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 15, p. 5283, doi. 10.1002/cam4.4085
- By:
- Publication type:
- Article
Efficacy and Safety of Lenalidomide for Treatment of Low-/Intermediate-1-Risk Myelodysplastic Syndromes with or without 5q Deletion: A Systematic Review and Meta-Analysis.
- Published in:
- PLoS ONE, 2016, v. 11, n. 11, p. 1, doi. 10.1371/journal.pone.0165948
- By:
- Publication type:
- Article
Whole-Genome DNA Methylation Sequencing Reveals Epigenetic Changes in Myelodysplastic Syndromes.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.897898
- By:
- Publication type:
- Article
Dysregulation of LINC00324 associated with methylation facilitates leukemogenesis in de novo acute myeloid leukemia.
- Published in:
- International Journal of Laboratory Hematology, 2022, v. 44, n. 3, p. 567, doi. 10.1111/ijlh.13809
- By:
- Publication type:
- Article
Methylation‐independent ITGA2 overexpression is associated with poor prognosis in de novo acute myeloid leukemia.
- Published in:
- Journal of Cellular Physiology, 2018, v. 233, n. 12, p. 9584, doi. 10.1002/jcp.26866
- By:
- Publication type:
- Article
Methylation-associated DOK1 and DOK2 down-regulation: Potential biomarkers for predicting adverse prognosis in acute myeloid leukemia.
- Published in:
- Journal of Cellular Physiology, 2018, v. 233, n. 9, p. 6604, doi. 10.1002/jcp.26271
- By:
- Publication type:
- Article
Hypomethylation-mediated H19 overexpression increases the risk of disease evolution through the association with BCR-ABL transcript in chronic myeloid leukemia.
- Published in:
- Journal of Cellular Physiology, 2018, v. 233, n. 3, p. 2444, doi. 10.1002/jcp.26119
- By:
- Publication type:
- Article
Changes of Litterfall Amount in Natural Secondary Forests and Chinese Fir Plantations of Different Forest Ages During the Restoration Process.
- Published in:
- Fujian Agricultural Science & Technology, 2022, v. 53, n. 1, p. 59, doi. 10.13651/j.cnki.fjnykj.2022.01.011
- By:
- Publication type:
- Article
SOX30 methylation correlates with disease progression in patients with chronic myeloid leukemia.
- Published in:
- OncoTargets & Therapy, 2019, v. 12, p. 4789, doi. 10.2147/OTT.S210168
- By:
- Publication type:
- Article
EZH2 dysregulation: Potential biomarkers predicting prognosis and guiding treatment choice in acute myeloid leukaemia.
- Published in:
- Journal of Cellular & Molecular Medicine, 2020, v. 24, n. 2, p. 1640, doi. 10.1111/jcmm.14855
- By:
- Publication type:
- Article
Establishment and molecular characterization of decitabine‐resistant K562 cells.
- Published in:
- Journal of Cellular & Molecular Medicine, 2019, v. 23, n. 5, p. 3317, doi. 10.1111/jcmm.14221
- By:
- Publication type:
- Article
ALOX5AP is a new prognostic indicator in acute myeloid leukemia.
- Published in:
- Discover Oncology, 2023, v. 14, n. 1, p. 1, doi. 10.1007/s12672-023-00826-9
- By:
- Publication type:
- Article
Comprehensive characterization of TGFB1 across hematological malignancies.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-46552-8
- By:
- Publication type:
- Article
Association Analyses of TP53 Mutation With Prognosis, Tumor Mutational Burden, and Immunological Features in Acute Myeloid Leukemia.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.717527
- By:
- Publication type:
- Article
SLC22A3 methylation-mediated gene silencing predicts adverse prognosis in acute myeloid leukemia.
- Published in:
- Clinical Epigenetics, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13148-022-01373-w
- By:
- Publication type:
- Article
Comprehensive analysis of SPAG1 expression as a prognostic and predictive biomarker in acute myeloid leukemia by integrative bioinformatics and clinical validation.
- Published in:
- BMC Medical Genomics, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s12920-022-01193-0
- By:
- Publication type:
- Article